arrow
L

Lakshmanane Premkumar

university of north carolina school of medicine
H指数:30
被引数:8,605

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Zika virus vaccine with E protein fusion loop mutations protects via CD8+ T cells

携带E蛋白融合环突变的寨卡病毒疫苗通过CD8+ T细胞提供保护

2026-08-260
OA
Severity-associated changes in ICOS, CD27, CD127, and CLA expression and expansion of virus-specific T cells in acute dengue

急性登革热中与严重程度相关的ICOS、CD27、CD127和CLA表达变化及病毒特异性T细胞的扩增

2026-08-180
PRE
Spatiotemporal Dynamics of the 2025–2026 Measles Outbreak in Mexico: Jalisco as the Emerging Epicenter and the Impact of Intensive Immunization Efforts

2025–2026年墨西哥麻疹疫情的空间-时间动态:哈利斯科州作为新兴暴发中心及强化免疫努力的影响

2026-05-280
OA
Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4+ T cells in chronic chikungunya disease

R. Agarwal, C. Ha, F. H. Cortes, Y. Lee, A. Martinez-Perez, R. I. Galvez, I. N. Castillo, E. J. Phillips, S. A. Mallal, A. Balmaseda, E. Harris, C. M. Romero-Vivas, L. Premkumar, A. K. Falconar, A. Grifoni, A. Sette, D. Weiskopf, 慢性基孔肯雅病中针对CD4+ T细胞的免疫原性和交叉反应性基孔肯雅病毒表位的鉴定。Nat. Commun. 16, 5756 (2025)。

2025-07-010
OAAI
COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort
2024-06-140
OAAI
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
2024-05-031
OAAI
Magnitude and Durability of the Antibody Response to mRNA-Based Vaccination Among SARS-CoV-2 Seronegative and Seropositive Health Care Personnel
2024-01-192
OAAI
Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes
2023-12-010
OAAI
SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition
2023-09-213
OAAI
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
2023-08-278
PRE
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
2023-04-0121
OAAI
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
MBIO
IF4.7
2022-10-267
OAAI